Tim Peoples

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database

Wearable biosensors for healthcare monitoring

Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data

Short-term prediction of future continuous glucose monitoring readings in type 1 diabetes: Development and validation of a neural network regression model

Mobile Applications for Control and Self Management of Diabetes: A Systematic Review

Type 1 diabetes

The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy

End-to-end design of wearable sensors

Use of Automated Bolus Calculators for Diabetes Management

A Clinical Trial of the Accuracy and Treatment Experience of the Dexcom G4 Sensor (Dexcom G4 System) and Enlite Sensor (Guardian REAL-Time System) Tested Simultaneously in Ambulatory Patients with Type 1 Diabetes

Is the Response of Continuous Glucose Monitors to Physiological Changes in Blood Glucose Levels Affected by Sensor Life?

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts

The Effect of Walking on Postprandial Glycemic Excursion in Patients With Type 1 Diabetes and Healthy People

The Effects of Animals on Human Health and Well‐Being

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12‐month data from the OpT2mise randomized trial

Hypoglycemia in diabetes.

Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association

Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study

Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR

The Past 200 Years in Diabetes

Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy

Continuous Glucose Monitoring Systems: A Review

Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence

Resource utilization with insulin pump therapy for type 2 diabetes mellitus.

Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

Baseline Predictors of A1C Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Therapy: The STAR 3 Experience

Accuracy Performance of the Medtronic NexSensor® for 6 Days in an Inpatient Setting Using Abdomen and Buttocks Insertion Sites